Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleThe State of the Art

Green Nuclear Medicine and Radiotheranostics

Patrick Veit-Haibach, Ken Herrmann, Richard Zimmermann and Roland Hustinx
Journal of Nuclear Medicine March 2025, 66 (3) 340-343; DOI: https://doi.org/10.2967/jnumed.124.268928
Patrick Veit-Haibach
1Joint Department of Medical Imaging, University Medical Imaging Toronto, University Health Network, Mount Sinai Hospital and Women’s College Hospital, University of Toronto, Toronto, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
2Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany;
3German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Zimmermann
4Chrysalium Consulting, Lalaye, France; MEDraysintell, Louvain-la-Neuve, Belgium; and Oncidium Foundation, Mont-Saint-Guibert, Belgium; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland Hustinx
5Division of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, CHU of Liège, Quartier Hôpital, Liège, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    The healthcare system contributes to approximately 5% of total carbon footprint worldwide. In terms of the most responsible activity for GHG production, “generation and distribution of electricity, gas and heat or cooling” has highest share (∼40%). Regarding the most responsible sector, “hospital care” contributes to more than one third of health care footprint.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (3)
Journal of Nuclear Medicine
Vol. 66, Issue 3
March 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Green Nuclear Medicine and Radiotheranostics
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Green Nuclear Medicine and Radiotheranostics
Patrick Veit-Haibach, Ken Herrmann, Richard Zimmermann, Roland Hustinx
Journal of Nuclear Medicine Mar 2025, 66 (3) 340-343; DOI: 10.2967/jnumed.124.268928

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Green Nuclear Medicine and Radiotheranostics
Patrick Veit-Haibach, Ken Herrmann, Richard Zimmermann, Roland Hustinx
Journal of Nuclear Medicine Mar 2025, 66 (3) 340-343; DOI: 10.2967/jnumed.124.268928
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • THE INCREASING RADIOPHARMACEUTICAL MARKET
    • GENERAL ENVIRONMENTAL IMPACT OF DIAGNOSTIC AND THERAPEUTIC MOLECULAR IMAGING PRODUCTION
    • ENVIRONMENTAL IMPACT OF HOSPITAL-BASED MOLECULAR IMAGING DEPARTMENTS
    • WHAT ARE THE OUT-OF-HOSPITAL SOLUTIONS?
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Is 211At Really Happening?
  • Google Scholar

More in this TOC Section

  • The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical Therapy
  • Rethinking Dosimetry: A European Perspective
  • A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry
Show more The State of the Art

Similar Articles

Keywords

  • molecular imaging
  • radionuclide therapy
  • radiopharmaceuticals
  • green nuclear medicine
  • radiotheranostics
  • health economics
SNMMI

© 2025 SNMMI

Powered by HighWire